Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 08:56 am Purchase | 2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | Deep Track Capital LP | 4,000,000 7.810% | 143,537 (+3.72%) | Filing History |
| 2022-02-14 08:55 am Purchase | 2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | RTW Investments, LP | 2,863,198 5.600% | 2,863,198 (New Position) | Filing History |
| 2022-02-11 4:27 pm Purchase | 2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | ORBIMED ADVISORS LLC | 2,200,200 4.300% | 2,200,200 (New Position) | Filing History |
| 2022-02-10 09:28 am Sale | 2021-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -2,768,840 (Position Closed) | Filing History |
| 2021-09-01 4:20 pm Purchase | 2021-08-31 | 13G | Jounce Therapeutics, Inc. JNCE | Deep Track Capital LP | 3,856,463 7.530% | 3,856,463 (New Position) | Filing History |
| 2021-04-05 5:26 pm Purchase | 2019-11-20 | 13G | Jounce Therapeutics, Inc. JNCE | BRISTOL MYERS SQUIBB CO BMY | 3,456,463 7.600% | 3,456,463 (New Position) | Filing History |
| 2021-02-16 4:06 pm Sale | 2020-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | Third Rock Ventures II L.P. | 12,339,828 31.000% | -939,292 (-7.07%) | Filing History |
| 2021-02-01 2:13 pm Purchase | 2021-01-20 | 13G | Jounce Therapeutics, Inc. JNCE | PFM Health Sciences, LP | 2,388,067 6.000% | 2,388,067 (New Position) | Filing History |
| 2021-01-29 4:12 pm Purchase | 2021-01-19 | 13G | Jounce Therapeutics, Inc. JNCE | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,768,840 6.950% | 2,768,840 (New Position) | Filing History |
| 2020-10-26 4:33 pm Purchase | 2020-10-16 | 13G | Jounce Therapeutics, Inc. JNCE | GILEAD SCIENCES INC. GILD | 5,539,727 13.900% | 5,539,727 (New Position) | Filing History |